136 related articles for article (PubMed ID: 38412847)
1. Evaluation of the Cytokine Response Induced by Specific Allergen Immunotherapy in Patients with Vespa velutina Anaphylaxis.
López-Freire S; Armisén M; Cruz MJ; Vidal C
Int Arch Allergy Immunol; 2024; 185(5):456-459. PubMed ID: 38412847
[TBL] [Abstract][Full Text] [Related]
2. Vespa velutina nigrithorax venom allergy: inhibition studies approach for the choice of specific immunotherapy.
Grossi V; Severino M; Massolo A; Infantino M; Laureti F; Macchia D; Meucci E; Francescato E; Pantera B; Ebbli A; Fumagalli F; Lari B; Perri A; Liotti I; Ciotta G; Terenzi G; Valeva SV; Consolati M; Folgore T; Manfredi M
Eur Ann Allergy Clin Immunol; 2023 Jul; 55(4):161-165. PubMed ID: 36515256
[No Abstract] [Full Text] [Related]
3. Anaphylaxis to Vespa velutina nigrithorax: Pattern of Sensitization for an Emerging Problem in Western Countries.
Vidal C; Armisén M; Monsalve R; González-Vidal T; Lojo S; López-Freire S; Méndez P; Rodríguez V; Romero L; Galán A; González-Quintela A
J Investig Allergol Clin Immunol; 2021 Jun; 31(3):228-235. PubMed ID: 32043465
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy with Vespula venom for Vespa velutina nigrithorax anaphylaxis: Preliminary clinical and immunological results.
Rodríguez-Vázquez V; Armisén M; Gómez-Rial J; Lamas-Vázquez B; Vidal C
Clin Exp Allergy; 2022 Feb; 52(2):345-347. PubMed ID: 34735733
[No Abstract] [Full Text] [Related]
5. Alternating Polistes-Vespula venom immunotherapy: a therapeutic strategy to resolve a diagnostic deficiency.
Moreno C; Barasona MJ; Serrano P; Justicia JL; Ruz JM; Guerra F
J Investig Allergol Clin Immunol; 2011; 21(1):28-33. PubMed ID: 21370720
[TBL] [Abstract][Full Text] [Related]
6. The safety and efficacy of immunotherapy with aluminum hydroxide-adsorbed venom extract of Vespula spp. An open, retrospective study.
Poli F; Longo G; Parmiani S
Allergol Immunopathol (Madr); 2001; 29(5):191-6. PubMed ID: 11720652
[TBL] [Abstract][Full Text] [Related]
7. Venom immunotherapy in patients with allergic reactions to insect stings.
Incorvaia C; Mauro M; Gritti BL; Makri E; Ridolo E
Expert Rev Clin Immunol; 2018 Jan; 14(1):53-59. PubMed ID: 29202591
[TBL] [Abstract][Full Text] [Related]
8. Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects.
Bellinghausen I; Metz G; Enk AH; Christmann S; Knop J; Saloga J
Eur J Immunol; 1997 May; 27(5):1131-9. PubMed ID: 9174602
[TBL] [Abstract][Full Text] [Related]
9. Initiating yellow jacket venom immunotherapy with a 100-μg dose: A challenge?
Vos BJPR; Dubois AEJ; Rauber MM; Pfützner W; Miehe M; Bohle B; Möbs C; Oude Elberink JNG
J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1332-1334.e4. PubMed ID: 30240885
[No Abstract] [Full Text] [Related]
10. Characterization of proliferative responses and cytokine mRNA profiles induced by Vespula venom in patients with severe reactions to wasp stings.
Bonay M; Echchakir H; Lecossier D; Lainé P; Herman D; Hance AJ; Soler P; Tazi A
Clin Exp Immunol; 1997 Aug; 109(2):342-50. PubMed ID: 9276531
[TBL] [Abstract][Full Text] [Related]
11. The Asian wasp Vespa velutina nigrithorax: Entomological and allergological characteristics.
Vidal C
Clin Exp Allergy; 2022 Apr; 52(4):489-498. PubMed ID: 34822191
[TBL] [Abstract][Full Text] [Related]
12. Social wasps in Spain: the who and where.
Vega JM; Ortiz-Sánchez FJ; Martínez-Arcediano A; Castro L; Alfaya T; Carballada F; Cruz S; Marqués L; Vega A; Ruiz-León B
Allergol Immunopathol (Madr); 2022; 50(2):58-64. PubMed ID: 35257546
[TBL] [Abstract][Full Text] [Related]
13. [The wasp/mosquito syndrome].
Sabbah A; Hassoun S; Drouet M; Lauret MG; Doucet M
Allerg Immunol (Paris); 1999 Jun; 31(6):175-84. PubMed ID: 10443298
[TBL] [Abstract][Full Text] [Related]
14. Regulatory T cell and cytokine changes in children undergoing 3 days rush venom immunotherapy.
Rattanamanee T; Lumjiaktase P; Kemawichanura N; Kiewgnam P; Jotikasthira W; Manuyakorn W
Asian Pac J Allergy Immunol; 2023 Sep; 41(3):193-198. PubMed ID: 33068370
[TBL] [Abstract][Full Text] [Related]
15. Hymenoptera sting anaphylaxis and urticaria pigmentosa: clinical findings and results of venom immunotherapy in ten patients.
Fricker M; Helbling A; Schwartz L; Müller U
J Allergy Clin Immunol; 1997 Jul; 100(1):11-5. PubMed ID: 9257781
[TBL] [Abstract][Full Text] [Related]
16. Safety profile of hymenoptera venom immunotherapy (VIT) in monosensitized patients: lack of new sensitization to nontreated insect venom.
Spoerl D; Bircher AJ; Scherer K
J Investig Allergol Clin Immunol; 2011; 21(1):22-7. PubMed ID: 21370719
[TBL] [Abstract][Full Text] [Related]
17. Rush hymenoptera venom immunotherapy is efficacious and safe.
Pasaoglu G; Sin BA; Misirligil Z
J Investig Allergol Clin Immunol; 2006; 16(4):232-8. PubMed ID: 16889280
[TBL] [Abstract][Full Text] [Related]
18. Wasp Venom Immunotherapy in a Patient With Immune-Mediated Inflammatory Central Nervous System Disease: Is it Safe?
Nittner-Marszalska M; Kowal A; Szewczyk P; Guranski K; Ejma M
J Investig Allergol Clin Immunol; 2017; 27(2):127-129. PubMed ID: 28398199
[No Abstract] [Full Text] [Related]
19. Wasp venom immunotherapy induces a shift from IL-4-producing towards interferon-gamma-producing CD4+ and CD8+ T lymphocytes.
Schuerwegh AJ; De Clerck LS; Bridts CH; Stevens WJ
Clin Exp Allergy; 2001 May; 31(5):740-6. PubMed ID: 11422133
[TBL] [Abstract][Full Text] [Related]
20. Honeybee and wasp venom allergy: Sensitization and immunotherapy.
Adib-Tezer H; Bayerl C
J Dtsch Dermatol Ges; 2018 Oct; 16(10):1228-1247. PubMed ID: 30300499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
